期刊文献+

人巨细胞病毒包膜糖蛋白B的B细胞抗原表位预测 被引量:1

B-cell Epitopes Prediction of Human Cytomegalovirus Glycoprotein B
下载PDF
导出
摘要 目的:通过生物信息学方法分析人巨细胞病毒包膜糖蛋白B(gB)的三级结构并预测其线性B细胞抗原表位.方法:根据人巨细胞病毒gB蛋白的胞外域序列,利用DNAStar软件分析其二级结构和表面特性,联合在线B细胞表位预测程序BcePred,通过其理化特性来综合预测该蛋白可能的线性B细胞抗原表位;利用SWISSMODEL服务器的同源建模方法构建gB蛋白的三级结构模型,对在生理三聚体条件下该蛋白各预测表位进行验证.结果:成功预测出人巨细胞病毒gB蛋白的多个线性B细胞抗原表位区段,其中预测出的5个表位区段不属于任何已发现的抗原区域,为后续验证其优势中和表位,研制安全、高效的表位疫苗奠定了理论基础. Objective: Using bioinformatics approaches, the B cell linear epitopes of Human Cytomegalovims GlycoproteinB (gB) are predicted by studying its physicochemical properties. Methods: Based on the sequence of the HCMV gB extracellular portion, the probable B cell epitopes of gB are analyzed with its secondary structure and surface properties through DNAstar software as well as the BcePred online program. Meanwhile, the tertiary structure of gB is constructed by homologous modelling with the assistance of SWISSMODEL server, analyzing the surface possibility of epitopes under the condition of physiological trimer. Results: This study successfully predicted several linear B cell epitopes of the extracellular portion of HCMV gB, in which 5 epitopes were reported for the first time. And this work could provide a theoretical foundation for further verification of the gB immunodominant epitopes and developing safe and effective epitope vaccines.
出处 《湖南师范大学自然科学学报》 CAS 北大核心 2013年第5期65-69,共5页 Journal of Natural Science of Hunan Normal University
基金 湖南省科技厅基金资助项目(2012SK3129 2011SK2014)
关键词 生物信息学 人巨细胞病毒 包膜糖蛋白B B细胞抗原表位 Bioinformatics human cytomegalovirus glycoprotein B B cell epitope
  • 相关文献

参考文献20

  • 1BOECKH M, LJUNGMAN P. How we treat cytomegalovirus in hematopoietic cell transplant recipients[ J ]. Blood, 2009,113 (23) :5711-5719.
  • 2BOPPANA S B, PASS R F, BRITI" W J, et al. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mor- tality [ J ]. Pediatr Infect Dis J, 1992,11:93-99.
  • 3SCHOPPEL K, KROPFF B, SCHMIDT C, et al. The humoral immune response against human cytomegalovirus is characterized by a delayed synthesis of glycoprotein-specific antibodies [ J ]. J Infect Dis, 1997,175 (3) :533-544.
  • 4MARSHALL G S, RABALAIS G P, STOUT G G, et al. Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity[J]. J Infect Dis, 1992,165(2) :381-384.
  • 5NAVARRO D, PAZ P, TUGIZOV S, et al. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells[ J]. Virology, 1993,197( 1 ) :143-158.
  • 6BERNSTEIN D I, REAP E A, KATEN K, et al. Randomized, double-blind, Phase 1 trim of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers [ J ]. Vaccine, 2009,28 (2) :484-493.
  • 7PASS R F, ZHANG C, EVANS A, et al. Vaccine prevention of maternal cytomegalovirus infection[J]. N Engl J Med, 2009, 360 : 1191-1199.
  • 8POTZSCH S, SPINDLER N, WIEGERS A K, et al. B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies[ J]. PLoS Pathog, 2011,7(8) :e1002172.
  • 9CHOU P Y, FASMAN G D . Prediction of the secondary structure of proteins from their amino acid sequence [ J ]. Adv Enzymol Relat Areas Mol Biol, 1978,47:45-148.
  • 10GARNIER J, OSGUTHORPE D J, ROBSON B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins[ J ]. J Mol Biol, 1978,120( 1 ) :97-120.

二级参考文献3

  • 1Daniel P. Dolata,Andrew R. Leach,Keith Prout. WIZARD: AI in conformational analysis[J] 1987,Journal of Computer - Aided Molecular Design(1):73~85
  • 2陈兴,王更银,丛爱丽,张立,许素菊.人DAO氨基酸序列片段B-细胞表位的多参数预测[J].免疫学杂志,2000,16(3):232-234. 被引量:32
  • 3QIN E'de,ZHU Qingyu,YU Man, FAN Baochang,CHANG Guohui,SI Bingyin,YANG Bao,PENG Wenming,JIANG Tao,LIU Bohua,DENG Yongqiang,LIU Hong,ZHANG Yu,WANG Cui,LI Yuquan,GAN Yonghua,LI Xiaoyu,L Fushuang,TAN Gang,CAO Wuchun,YANG Ruifu,WANG Jian,LI Wei,XU Zuyuan,LI Yan,WU Qingfa,LIN Wei,CHEN Weijun,TANG Lin,DENG Yajun,HAN Yujun,LI Changfeng,LEI Meng,LI Guoqing,LI Wenjie,L Hong,SHI Jianping,TONG Zongzhong,ZHANG Feng,LI Songgang,LIU Bin,LIU Siqi,DONG Wei,WANG Jun,Gane K-S Wong,YU Jun,YANG Huanming.A complete sequence and comparative analysis of a SARS-associated virus(Isolate BJ01)[J].Chinese Science Bulletin,2003,48(10):941-948. 被引量:122

共引文献50

同被引文献4

  • 1Mohamed A Kharfan-Dabaja,Michael Boeckh,Marissa B Wilck,Amelia A Langston,Alice H Chu,Mary K Wloch,Don F Guterwill,Larry R Smith,Alain P Rolland,Richard T Kenney.A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial[J].The Lancet Infectious Diseases.2012(4)
  • 2Paul D Griffiths,Anna Stanton,Erin McCarrell,Colette Smith,Mohamed Osman,Mark Harber,Andrew Davenport,Gareth Jones,David C Wheeler,James O’Beirne,Douglas Thorburn,David Patch,Claire E Atkinson,Sylvie Pichon,Paul Sweny,Marisa Lanzman,Elizabeth Woodford,Emily Rothwell,Natasha Old,Ruth Kinyanjui,Tanzina Haque,Sowsan Atabani,Suzanne Luck,Steven Prideaux,Richard SB Milne,Vincent C Emery,Andrew K Burroughs.Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial[J].The Lancet.2011(9773)
  • 3Ian A Ramshaw,Alistair J Ramsay.The prime-boost strategy: exciting prospects for improved vaccination[J].Immunology Today.2000(4)
  • 4Stanley A. Plotkin,Robert Higgins,John B. Kurtz,Peter J. Morris,Darrell A. Campbell,Thomas C. Shope,Stephen A. Spector,Wayne M. Dankner.MULTICENTER TRIAL OF TOWNE STRAIN ATTENUATED VIRUS VACCINE IN SERONEGATIVE RENAL TRANSPLANT RECIPIENTS[J].Transplantation.1994(11)

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部